Bath & Body Works Announces Appointment of Thomas J. Kuhn 6-03-2023, 19:34

HRH Crown Prince launches Soudah Peaks’ masterplan 27-09-2023, 11:14

Teva Presents Latest Schizophrenia Treatment Research, Including Phase 3 SOLARIS Trial Results Demonstrating Improvements in Social Functioning and Quality of Life in Adults Receiving TEV-'749 (olanzapine) a Subcutaneous Long-Acting Injectable as well as 2-11-2024, 02:00